Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
ChromaDex Corp. (NASDAQ:CDXC) announced today that Charles Brenner, PhD, the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa Carver College of Medicine and current ChromaDex Scientific Advisory Board member, has been appointed Chief Scientific Advisor.
June 5, 2017
1 Min Read
.png?width=850&auto=webp&quality=95&format=jpg&disable=upscale "ChromaDex Announces New Chief Scientific Advisor")
ChromaDex Corp. (NASDAQ:CDXC) announced today that Charles Brenner, PhD, the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa Carver College of Medicine and current ChromaDex Scientific Advisory Board member, has been appointed Chief Scientific Advisor.
You May Also Like
Recommended
.png?width=800&auto=webp&quality=80&disable=upscale)